Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Lamont Larkin
Andrew Lamont Larkin
GlaxoSmithKline
Inverse agonist
Opioid receptor
Receptor
Diabetes mellitus
Chemistry
2
Papers
80
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist.
2012
The Journal of Clinical Pharmacology
Pradeep J. Nathan
Barry V. ONeill
Mark A. Bush
Annelize Koch
Wenli X. Tao
Kay Maltby
Antonella Napolitano
Allison C. Brooke
Andrew L. Skeggs
Craig S. Herman
Andrew Lamont Larkin
Diane M. Ignar
Duncan Richards
Pauline Williams
Edward T. Bullmore
Show All
Source
Cite
Save
Citations (43)
Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist
2011
Journal of Pharmacology and Experimental Therapeutics
Diane M. Ignar
Aaron Goetz
Kimberly Nichols Noble
Luz Helena Carballo
Andrea E. Stroup
Julie C. Fisher
Joyce A. Boucheron
Tracy A. Brainard
Andrew Lamont Larkin
Andrea H. Epperly
Todd W. Shearer
Scott D. Sorensen
Jason Speake
Jonathan D. Hommel
Show All
Source
Cite
Save
Citations (37)
1